KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Operating Expenses (2016 - 2025)

Astrana Health (ASTH) has disclosed Operating Expenses for 16 consecutive years, with $932.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 40.28% to $932.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 billion through Dec 2025, up 59.53% year-over-year, with the annual reading at $3.1 billion for FY2025, 59.53% up from the prior year.
  • Operating Expenses hit $932.1 million in Q4 2025 for Astrana Health, down from $936.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $936.8 million in Q3 2025 to a low of $154.3 million in Q1 2021.
  • Historically, Operating Expenses has averaged $403.3 million across 5 years, with a median of $318.0 million in 2023.
  • Biggest five-year swings in Operating Expenses: dropped 4.02% in 2021 and later skyrocketed 108.05% in 2025.
  • Year by year, Operating Expenses stood at $192.9 million in 2021, then skyrocketed by 46.03% to $281.6 million in 2022, then grew by 26.73% to $356.9 million in 2023, then surged by 86.18% to $664.5 million in 2024, then skyrocketed by 40.28% to $932.1 million in 2025.
  • Business Quant data shows Operating Expenses for ASTH at $932.1 million in Q4 2025, $936.8 million in Q3 2025, and $634.5 million in Q2 2025.